Groowe / Newsroom / SRPT

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SRPT News

Sarepta Therapeutics,, Inc. Common Stock

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sarepta Therapeutics, Inc. (SRPT) and Encourages Investors to Learn More About the Investigation

accessnewswire.com Dec 26, 2025 5:00 PM

Sarepta Therapeutics, Inc. (SRPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

accessnewswire.com Dec 25, 2025 5:00 PM

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sarepta Therapeutics, Inc. (SRPT) And Encourages Investors to Connect

accessnewswire.com Dec 24, 2025 5:00 PM

Bronstein, Gewirtz & Grossman, LLC Encourages Sarepta Therapeutics, Inc. (SRPT) Stockholders to Inquire about Securities Investigation

accessnewswire.com Dec 23, 2025 5:00 PM

Bronstein, Gewirtz & Grossman, LLC Encourages Sarepta Therapeutics, Inc. (SRPT) Investors to Inquire about Securities Investigation

accessnewswire.com Dec 22, 2025 5:00 PM

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Investors to Reach Out

accessnewswire.com Dec 21, 2025 5:00 PM

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Stockholders to Reach Out

accessnewswire.com Dec 19, 2025 5:00 PM

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sarepta Therapeutics, Inc. (SRPT) And Encourages Stockholders to Connect

accessnewswire.com Dec 18, 2025 5:00 PM

Sarepta Therapeutics, Inc. (SRPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

accessnewswire.com Dec 17, 2025 5:00 PM

Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™

globenewswire.com Dec 15, 2025 3:30 PM

BIIB ALNY SRPT JAZZ PFE JNJ BMRN QURE AMGN